Search Results - "MacCumber, Mathew"

Safety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration: Results From the IRIS Registry and Komodo Healthcare Map by Khanani, Arshad M, Zarbin, Marco A, Barakat, Mark R, Albini, Thomas A, Kaiser, Peter K, B, Guruprasad, Agashivala, Neetu, Yu, Justin S, Wykoff, Charles C, MacCumber, Mathew W

“…Limited data exist on the real-world safety outcomes of patients with neovascular age-related macular degeneration treated with brolucizumab (Beovu). To…”
Get more information

PREOPERATIVE DOMED MACULAR CONTOUR CORRELATES WITH POSTOPERATIVE VISUAL GAIN AFTER VITRECTOMY FOR SYMPTOMATIC EPIRETINAL MEMBRANE by Zeyer, John C., Parker, Paul, Dajani, Omar, MacCumber, Mathew W.

“…Evaluate macular features on preoperative ocular coherence tomography as indicators of postoperative visual gain following vitrectomy for epiretinal membrane…”
Get full text

One-Year Brolucizumab Outcomes in Neovascular Age-Related Macular Degeneration from a Large United States Cohort in the IRIS® Registry by MacCumber, Mathew W., Wykoff, Charles C., Karcher, Helene, Adiguzel, Eser, Sinha, Samriddhi Buxy, Vishwakarma, Saloni, LaPrise, Andrew, Igwe, Franklin, Freitas, Rita, Ip, Michael S., Zarbin, Marco A.

“…To evaluate visual acuity (VA) and injection intervals in patients with neovascular age-related macular degeneration (nAMD) after 12 months of brolucizumab…”
Get full text

The Real-World Effect of Intravitreous Anti-Vascular Endothelial Growth Factor Drugs on Intraocular Pressure: An Analysis Using the IRIS Registry by Atchison, Elizabeth A, Wood, Kevin M, Mattox, Cynthia G, Barry, Catherine N, Lum, Flora, MacCumber, Mathew W

“…To identify sustained differences in intraocular pressure (IOP) after intravitreous injections of anti-vascular endothelial growth factor (VEGF) drugs…”
Get full text

Factors Linked to Injection Interval Extension in Eyes with Wet Age-Related Macular Degeneration Switched to Brolucizumab by MacCumber, Mathew W., Wykoff, Charles C., Karcher, Helene, Adiguzel, Eser, Sinha, Samriddhi Buxy, Vishwakarma, Saloni, LaPrise, Andrew, Igwe, Franklin, Freitas, Rita, Ip, Michael S., Zarbin, Marco A.

“…To evaluate factors associated with anti–vascular endothelial growth factor (VEGF) injection interval extension in patients with neovascular age-related…”
Get full text

Recommendations for Genetic Testing of Inherited Eye Diseases: Report of the American Academy of Ophthalmology Task Force on Genetic Testing by STONE, Edwin M, ALDAVE, Anthony J, DRACK, Arlene V, MACCUMBER, Mathew W, SHEFFIELD, Val C, TRABOULSI, Elias, WELEBER, Richard G

“…Genetic testing can make a very positive impact on individuals and families affected with inherited eye disease in a number of ways. When properly performed,…”
Get full text

Castleman Disease and Retinal Vascular Tortuosity by Aung, Andre, MacCumber, Mathew W

Get more information

Outcomes of dislocated intraocular lens repair with McCannel suture by Yu, Bryant K., Packo, Kirk H., MacCumber, Mathew W.

Get full text

Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40 by Jhaveri, Chirag D., Liu, Danni, Maguire, Maureen G., Glassman, Adam R., Grigorian, Ruben A., Jampol, Lee M., Kingsley, Ronald M., MacCumber, Mathew W., Martin, Daniel F., Maturi, Raj K., Velez, Gisela, Sun, Jennifer K.

“…To identify factors for meeting prespecified criteria for switching from bevacizumab to aflibercept in eyes with center-involved diabetic macular edema…”
Get full text

Antivascular endothelial growth factor agents for wet age-related macular degeneration: an IRIS registry analysis by MacCumber, Mathew W., Yu, Justin S., Sagkriotis, Alexandros, B, Guruprasad, Burugapalli, Bhavya, Bi, Xiaoyu, Agashivala, Neetu, Wykoff, Charles C.

“…To evaluate treatment patterns and outcomes of patients in the United States who received antivascular endothelial growth factor (anti-VEGF) agents for wet…”
Get full text

Pneumatic Vitreolysis with Perfluoropropane for Vitreomacular Traction with and without Macular Hole: DRCR Retina Network Protocols AG and AH by Chan, Clement K, Mein, Calvin E, Glassman, Adam R, Beaulieu, Wesley T, Calhoun, Claire T, Jaffe, Glenn J, Jampol, Lee M, MacCumber, Mathew W, Maguire, Maureen G, Maturi, Raj K, Salehi-Had, Hani, Rofagha, Soraya, Sun, Jennifer K, Martin, Daniel F

“…To evaluate pneumatic vitreolysis (PVL) in eyes with vitreomacular traction (VMT) with and without full-thickness macular hole (FTMH). Two multicenter (28…”
Get full text

Levodopa is associated with reduced development of new-onset geographic atrophy in patients with age-related macular degeneration by Chan, Kyle S, Aggarwal, Nitika, Lawson, Shannon, Boucher, Nick, MacCumber, Mathew W, Lavine, Jeremy A

“…Background Geographic atrophy (GA) is a significant cause of vision loss in patients with age-related macular degeneration (AMD). Current treatments are…”
Get full text

Surgical Outcomes of Rhegmatogenous Retinal Detachment and Fellow Eye Involvement in Adolescent and Young Adult Patients by Bomdica, Prithvi R, MacCumber, Mathew W, Abdel-Hadi, Sarah, Parker, Makena, Minaker, Samuel

“…To investigate the associations, fellow eye retinal tear or detachment, and surgical outcomes of rhegmatogenous retinal detachments (RRDs) in young adults…”
Get more information

Analysis of Posterior Vitreous Detachment and Development of Complications Using a Large Database of Retina Specialists by Patel, Palak R, Minkowski, Jonathan, Dajani, Omar, Weber, Jacob, Boucher, Nick, MacCumber, Mathew W

“…To examine the incidence of complications after posterior vitreous detachment (PVD) through an extended follow-up period and to identify patient-specific…”
Get more information

Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry by Zarbin, Marco A., MacCumber, Mathew W., Karcher, Helene, Adiguzel, Eser, Mayhook, Andrew, LaPrise, Andrew, Bilano, Ver L., Igwe, Franklin, Ip, Michael S., Wykoff, Charles C.

“…Introduction To assess real-world safety outcomes for adults with neovascular age-related macular degeneration (nAMD) treated with brolucizumab from the…”
Get full text

Vitreous Seeding of Renal Cell Carcinoma in a Patient Receiving Checkpoint Inhibitors by Dajani, Omar, Wong, Anthony, Coleman, Alyssa, Shepherd, Emily A., Wind, Kenneth P., MacCumber, Mathew W.

“…PURPOSETo describe a case of vitreous seeding with tractional retinal detachment as a result of metastatic renal cell carcinoma in a patient on systemic…”
Get full text

Didanosine-associated retinal toxicity in adults infected with human immunodeficiency virus by Gabrielian, Anna, MacCumber, Mathew M, Kukuyev, Alla, Mitsuyasu, Ronald, Holland, Gary N, Sarraf, David

Get more information

Intravitreal bevacizumab for postoperative recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy by Ferenchak, Kevin, Duval, Renaud, Cohen, Jack A, MacCumber, Mathew W

“…To describe the experience of authors using intravitreal bevacizumab (IVB) for eyes with recurrent vitreous hemorrhage (VH) after vitrectomy for proliferative…”
Get full text

Levodopa Is Associated with Reduced Development of Neovascular Age-Related Macular Degeneration by Hyman, Max J, Skondra, Dimitra, Aggarwal, Nitika, Moir, John, Boucher, Nick, McKay, Brian S, MacCumber, Mathew W, Lavine, Jeremy A

“…To determine whether levodopa (L-DOPA) is associated with a reduced likelihood of developing neovascular age-related macular degeneration (AMD). Three studies…”
Get more information

Lowered intraocular pressure in a glaucoma patient after intravitreal injection of ocriplasmin by McClintock, Michael, MacCumber, Mathew W

“…We report the case of a glaucoma patient who received a single intravitreal injection of 125 µg ocriplasmin for vitreomacular traction in the right eye. The…”
Get full text